Recombinant interferon alfa-2b treatment of necrobiotic xanthogranuloma with paraproteinemia.
Venencie
P Y
PY
Department of Dermatology, CHU Bicêtre, Le Kremlin Bicêtre, France.
Le Bras
P
P
Toan
N D
ND
Tchernia
G
G
Delfraissy
J F
JF
D000368:Aged; D005260:Female; D006099:Granuloma / Q000150:complications / Q000628:therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007145:Immunoglobulin kappa-Chains / Q000097:blood; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D017441:Necrobiotic Disorders / Q000150:complications / Q000628:therapy*; D010265:Paraproteinemias / Q000150:complications / Q000628:therapy*; D011994:Recombinant Proteins; D014973:Xanthomatosis / Q000150:complications / Q000628:therapy*
D007074:Immunoglobulin G; D007145:Immunoglobulin kappa-Chains; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins